Table 2.
Biologically important MT1 receptor variants
Amino acid change | Type of variant | Description | Reference |
---|---|---|---|
I49N | Missense mutation | Rare variant identified in autism spectrum disorder patients, impaired cell surface expression, melatonin binding, cAMP inhibition and ERK1/1 activation | Chaste et al., 2010 |
R54W | Missense mutation | Common variant identified in control population without obvious functional defect | Ebisawa et al., 1999 |
A157V | Missense mutation | Common variant identified in control population without obvious functional defect | Chaste et al., 2010; Ebisawa et al., 1999 |
G166E | Missense mutation | Common variant identified in control population, impaired cell surface expression, reduced cAMP inhibition and ERK1/2 activation | Chaste et al., 2010 |
Y170X | Nonsense mutation | Rare variant identified in attention‐deficit hyperactivity disorder (ADHD) patient, premature STOP codon with impaired cell surface expression and cAMP inhibition | Chaste et al., 2011 |
I212T | Missense mutation | Common variant identified in control population, impaired cell surface expression, cAMP inhibition and reduced ERK1/2 activation | Chaste et al., 2010 |
A266V | Missense mutation | Common variant identified in control population with reduced ERK1/2 activation | Chaste et al., 2010 |
K334N | Missense mutation | Rare variant identified in control population with reduced cAMP inhibition | Chaste et al., 2010 |
Common [minor allelic frequency (MAF) >1%], rare (MAF 0.1–1%) variants.